ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Agile Therapeutics Inc

Agile Therapeutics Inc (AGRX)

0.6022
0.00
(0.00%)
At close: September 23 4:00PM
0.6022
0.00
( 0.00% )

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.6022
Bid
0.27
Ask
0.2994
Volume
-
0.00 Day's Range 0.00
0.504 52 Week Range 2.6063
Previous Close
0.6022
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

AGRX Latest News

Agile Therapeutics Inc. Announces Completion of Acquisition by Insud Pharma, S.L.

Agile Therapeutics has combined with Insud Pharmaโ€™s US Subsidiary, Exeltis USA, Inc., expanding an already significant womenโ€™s health/contraceptive portfolio Agile Therapeutics Common...

Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L.

Agile Therapeutics will combine with Insud Pharmaโ€™s US Subsidiary, Exeltis, expanding an already significant Womenโ€™s Health/contraceptive portfolio Agile Therapeutics Common Shareholders expected...

Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

First Quarter Net Revenue Increased 58% and Factory Sales Increased 3% from Fourth Quarter 2023 Twirla First Quarter 2024 Demand Rebounded 18% from Fourth Quarter 2023 PRINCETON, N.J., May 15...

Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update

Full Year 2023 Net Revenue Increased 80% from 2022 While OPEX Decreased 33% Twirla Demand and Factory Sales Up 121% and 114% Respectively in 2023 vs 2022 Company Completes Pay-Off of Debt...

Agile Therapeutics Announces Delisting from Nasdaq

PRINCETON, N.J., March 25, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) (โ€œAgile Therapeuticsโ€ or the โ€œCompanyโ€), a women's healthcare company, today announced that the...

Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024

PRINCETON, N.J., March 21, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc.ย (Nasdaq: AGRX), a women's healthcare company, today announced it will report fourth quarter and full year 2023...

Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024

PRINCETON, N.J., March 20, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc.ย (Nasdaq: AGRX), a women's healthcare company, today announced it will report fourth quarter and full year 2023...

Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution

PRINCETON, N.J., March 13, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) (โ€œAgileโ€ or the โ€œCompanyโ€), a women's healthcare company, today announced that it has paid-off the...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.60220.60220.602200CS
4000.60220.60220.602200CS
12000.60220.60220.602200CS
260.03626.395759717310.5660.6111050.518206510.6022CS
52-1.1678-65.97740112991.772.60630.5041827760.91949693CS
156-51.8978-98.85295238152.5218.50.504217753438.07658511CS
260-56.8978-98.952695652257.5238.260.504215727969.97912121CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MSSMaison Solutions Inc
$ 1.30
(81.82%)
619.74k
EDUCEducational Development Corporation
$ 2.85
(41.79%)
1.42M
BLUEbluebird bio Inc
$ 0.6438
(31.71%)
5.35M
LWAYLifeway Foods Inc
$ 25.00
(16.99%)
26.94k
MEGLMagic Empire Global Limited
$ 0.5299
(16.72%)
7.04k
BIVIBioVie Inc
$ 1.64
(-42.46%)
48.17k
RCATRed Cat Holdings Inc
$ 2.71
(-14.10%)
195.58k
EJHE Home Household Service Holdings Ltd
$ 0.0926
(-9.13%)
1.15M
JFBRJeffs Brands Ltd
$ 0.342
(-7.07%)
21.64k
IPHAInnate Pharma SA
$ 2.08
(-6.31%)
530
BLUEbluebird bio Inc
$ 0.6438
(31.71%)
5.35M
NVDANVIDIA Corporation
$ 116.14
(-0.09%)
2.28M
IGIBiShares Trust iShares 5 to 10 Year Investment Grade Corp Bond
$ 53.785
(0.01%)
2.27M
XPONExpion360 Inc
$ 0.11
(-3.85%)
1.49M
EDUCEducational Development Corporation
$ 2.85
(41.79%)
1.42M

AGRX Discussion

View Posts
Renee Renee 4 weeks ago
AGRX: Shareholders of Agile Therapeutics, Inc. (AGRX) will receive $1.52/share in connection with the merger with Insud Pharma S.L

FINRA deleted symbol:

https://otce.finra.org/otce/dailyList?viewType=Deletions
๐Ÿ‘๏ธ0
davidsson10 davidsson10 3 months ago
https://www.otcmarkets.com/stock/AGRX/news/Agile-Therapeutics-Inc-Announces-Definitive-Merger-Agreement-with-Insud-Pharma-SL?id=445020
๐Ÿ‘๏ธ0
motleytool motleytool 6 months ago
Your welcome!
๐Ÿ‘๏ธ0
Doubledown75 Doubledown75 6 months ago
Thanks
๐Ÿ‘๏ธ0
motleytool motleytool 6 months ago
CTB fees over 200% now...pressure is building for a huge rip.
๐Ÿ‘๏ธ0
motleytool motleytool 6 months ago
CTB fees over 100% and float less than 10 mil. Strong bounce coming.
๐Ÿ‘๏ธ0
Monksdream Monksdream 6 months ago
AGRX new 52 week lo
๐Ÿ‘๏ธ0
motleytool motleytool 6 months ago
Looking tasty for a swing.
๐Ÿ‘๏ธ0
Renee Renee 6 months ago
AGRX delisted from the Nasdaq to the OTC. Stock dropped 62% from .54 to .21 after hours.

https://otce.finra.org/otce/dailyList?viewType=Additions
๐Ÿ‘๏ธ0
Monksdream Monksdream 6 months ago
AGRX new 52 week lo
๐Ÿ‘๏ธ0
Awl416 Awl416 6 months ago
Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution
๐Ÿ‘๏ธ0
Monksdream Monksdream 6 months ago
AGRX new 52 week low
๐Ÿ‘๏ธ0
Monksdream Monksdream 6 months ago
AGRX 10Q due March 13
๐Ÿ‘๏ธ0
Monksdream Monksdream 7 months ago
AGRX 10Q due March 6
๐Ÿ‘๏ธ0
Monksdream Monksdream 7 months ago
AGRX new 52 week low
๐Ÿ‘๏ธ0
Monksdream Monksdream 7 months ago
AGRX new 52=week low
๐Ÿ‘๏ธ0
Monksdream Monksdream 7 months ago
Ha!
๐Ÿ‘๏ธ0
Monksdream Monksdream 7 months ago
AGRX new 52 week low
๐Ÿ‘๏ธ0
Monksdream Monksdream 7 months ago
AGRX new 52 week low
๐Ÿ‘๏ธ0
Monksdream Monksdream 7 months ago
AGRX new 52 week low
๐Ÿ‘๏ธ0
Monksdream Monksdream 8 months ago
AGRX new 52 week low
๐Ÿ‘๏ธ0
Monksdream Monksdream 9 months ago
AGRX new 52 week low
๐Ÿ‘๏ธ0
Stockexpertpro Stockexpertpro 1 year ago
APLS Time to Cover Shorts just like i told the shorts last week on ARGX to Buy to Cover
๐Ÿ‘๏ธ0
Invest-in-America Invest-in-America 1 year ago
AGRX: WOW!! O.K., I can handle that!!
๐Ÿ‘๏ธ0
subslover subslover 1 year ago
The float is limited to under 1 mil shares so if this goes $10 I wouldn't be surprised
๐Ÿ‘๏ธ0
Invest-in-America Invest-in-America 1 year ago
AGRX: Heck, I had to launch my "DDAmanda-Time-Machine" (see ME, below) to recall MY post way back then, Dude!! (But, THANKS for the huge heads-up, Boss!!!)

๐Ÿ‘๏ธ0
subslover subslover 1 year ago
Agile Therapeutics Announces New Agreement with vitaCare® Prescription Services to Improve Access to Twirla®
Agile Plans to Increase Twirla prescriptions filled through telemedicine platforms that utilize vitaCare, such as Twentyeight Healthโ„ข

Partnership Expected to Augment Future Growth in the Retail Channel, the Companyโ€™s Most-Profitable Channel

Expanding Commercial Reach through Strategic Partnerships Continues to Drive Companyโ€™s Belief in Achieving 2023 Net Revenue in the Range of $25-$30 Million

PRINCETON, N.J., June 13, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq: AGRX), a women's healthcare company, today announced an agreement with vitaCare Prescription Services, a wholly owned subsidiary of GoodRx, to expand patient access and streamline fulfillment for Twirla (levonorgestrel ethinyl estradiol) transdermal system. VitaCare is a technology and services platform that helps patients navigate key access barriers for branded medications.

โ€œThe agreement with vitaCare aligns with our strategy to utilize partnerships to efficiently grow Twirla while continuing to responsibly manage our operating expenses,โ€ said Agile Therapeuticsโ€™ Chief Commercial Officer Amy Welsh.

โ€œThe goal for the vitaCare partnership is to strengthen Twirlaโ€™s already meaningful momentum in our most profitable channel โ€“ the retail channel. We believe the partnership with vitaCare will create more opportunity to reach new Twirla patients for whom access has been a barrier, while helping existing Twirla patients stay on therapy. Our on-going plan is to expand our commercial reach, which we expect will contribute to reaching our key 2023 financial goals of generating positive cash flow and delivering net revenue in the range of $25-$30 million.โ€

Agile continues to grow Twirlaโ€™s presence on telemedicine platforms, including Twentyeight Health, in addition to existing partners like Pandia Health and Nurx as more women choose telemedicine for their contraceptive needs. Twentyeight Health is a telehealth company providing affordable access and convenience for reproductive and sexual health and recently acquired the platform assets for SimpleHealth. The Company believes that the Twentyeight Health platform will provide an opportunity for more patients to learn about and access Twirla.
๐Ÿ‘๏ธ0
MomsSpaghetti MomsSpaghetti 2 years ago
Premarket craziness today :)
๐Ÿ‘๏ธ0
MomsSpaghetti MomsSpaghetti 2 years ago
Bounce coming
๐Ÿ‘๏ธ0
MomsSpaghetti MomsSpaghetti 2 years ago
Louis Rossman with 122k subscribers on YouTube that covers technology repairs (i know unrelated)... while talking left this stock up on his screen for a good bit while talking.

That's a lot of eyes... it's a sign to buy this for a quick run in my opinion.
๐Ÿ‘๏ธ0
ErnieBilco ErnieBilco 2 years ago
What a shit show operation.

The lawyer's base salary is 3 times their 6 month profit with an almost automatic 45% "bonus" for a company that LOSES MONEY as a business.

Time for the board to be replaced with active brain cells in their directors.
๐Ÿ‘๏ธ0
TradeNaked TradeNaked 2 years ago
$AGRX .47 buy =)
๐Ÿ‘๏ธ0
seventhcircle seventhcircle 2 years ago
agrx 52 week low

๐Ÿ‘๏ธ0
bcapps66 bcapps66 2 years ago
They upgrade guidance and the stock goes down? Wtf is up with this thang?????
๐Ÿ‘๏ธ0
stock1ace1 stock1ace1 2 years ago
.72 close breakout watch tomorrow
๐Ÿ‘๏ธ0
bcapps66 bcapps66 2 years ago
Offering closed! Sweet!
๐Ÿ‘๏ธ0
bcapps66 bcapps66 2 years ago
An offering always PROPOSED/POSITIONED to grown the business. Time will tell....
๐Ÿ‘๏ธ0
bcapps66 bcapps66 2 years ago
The only thing we can hope for is to cancel the offering (seen this on multiple bios this week). Because without that, a reverse is coming right after the offering is closed. Get ready to pull that trigger!
๐Ÿ‘๏ธ0
Dasqeezr Dasqeezr 2 years ago
Thought it might be a way to grow business but wasnt sure. Thanks
๐Ÿ‘๏ธ0
rcaselli rcaselli 2 years ago
Money buys ships and grows the business.
๐Ÿ‘๏ธ0
Dasqeezr Dasqeezr 2 years ago
SHELF OFFERING is that a good thing or bad thing as we see it.
๐Ÿ‘๏ธ0
alchemytrader alchemytrader 2 years ago
Back in at $1.75, looking to flip again today. Anything under $1.80 looks great!

if you liked it at 1.75 youre lovin it at .66
๐Ÿ‘๏ธ0
ErnieBilco ErnieBilco 2 years ago
Time to buy
๐Ÿ‘๏ธ0
bcapps66 bcapps66 2 years ago
Yeah...priced at .90 and it's in the .60's? Jesus...
๐Ÿ‘๏ธ0
crudeoil24 crudeoil24 2 years ago
Shelf offering : SEC FORM S-1 >
๐Ÿ‘๏ธ0
bcapps66 bcapps66 2 years ago
Well isn't this just awesome
๐Ÿ‘๏ธ0
basssque basssque 2 years ago
Back in at $1.75, looking to flip again today. Anything under $1.80 looks great!
๐Ÿ‘๏ธ0
basssque basssque 2 years ago
Buy this dip! Easy money flip later today
๐Ÿ‘๏ธ0
subslover subslover 2 years ago
Agile Therapeutics Stock Surges 70%
By RTTNews Staff Writer ? | Published: 6/28/2022 10:57 AM ET
Shares of Agile Therapeutics, Inc. (AGRX) are surging over 70% on Tuesday morning despite no stock-related new release from the company.

AGRX is currently trading at $2.1608, up $0.8908 or 70.1417%, on the Nasdaq. The stock opened its trading at $1.67 after closing Monday's trading at $1.27.

Agile Therapeutics, a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Intelligent Investor.
Biotech Stocks Facing FDA Decision In June 2022
Biotech Stocks Facing FDA Decision In June 2022

Biotech Stocks Facing FDA Decision In March 2022
Biotech Stocks Facing FDA Decision In March 2022

Biotech Stocks Facing FDA Decision In February 2022 non small cell lung cancer chemotherapy
Biotech Stocks Facing FDA Decision In February 2022

Previous StoryNext Story


Latest Updates on COVID-19
18K New Covid Cases, 144 Deaths In US
184K New Covid Cases, 860 Deaths In U.S.
50K New Covid Cases, 80 Deaths In U.S.
Sanofi-GSK Reports Positive Data From COVID-19 Beta-containing Vaccine Trial
FDA Advisers Recommend Pfizer, Moderna COVID-19 Vaccines For Kids As Young As 6 Months
Read MoreCOVID-19: Drugs in Development
RELATED NEWS
Agile Therapeutics Stock Surges 70%

Follow RTT
FacebookTwitterInstagramRSS
Editor's Pick Most Read Most Emailed
FDA Proposes Rule To Advance Consumer Access To OTC Drugs
US To Get 21 Mln Bottles Of Bellamy's Organic Infant Formula From Australia
Flight Cancellations, Delays On The Rise In US
FSIS Warns Against Ineligible Siluriformes Products Imported From Korea
Panera At Home Southwest Corn Chowder Recalled
MTD Products Recalls Walk-Behind Self-Propelled Lawn Mowers
Nike To Fully Exit Russia As Ukraine Invasion Continues
FDA Action Plan To Speed Up Drug Development For Rare Neurodegenerative Diseases
Loctek Recalls Fleximouts Overhead Garage Storage Racks
US To Import Millions Of Infant Formula Bottles From UK, Australia, Mexico
CVS Magnesium Citrate Saline Laxative Oral Solution Lemon Flavor Recalled
FDA Probes Death Of Infant Who Consumed Abbott Infant Formula



Copyright © 2022 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service.
About Us | Contact Us | Privacy | Sitemap
Share to Facebook
Share to Twitter
Share to Pinterest
Share to Email
๐Ÿ‘๏ธ0
DarthYoshi!! DarthYoshi!! 2 years ago
These biotechs can really run when they have good news. Biotechs have been really beaten down lately...
๐Ÿ‘๏ธ0

Your Recent History

Delayed Upgrade Clock